Evidence map›Paper›PMID 37541693›Full record

ArticleBMJ global health2023

Safe and effective treatments are needed for cryptosporidiosis, a truly neglected tropical disease.

Ian H Gilbert, Sumiti Vinayak, Boris Striepen, Ujjini H Manjunatha, Ibrahim A Khalil, Wesley C Van Voorhis, Cryptosporidiosis Therapeutics Advocacy Group CTAG, Cryptosporidiosis Therapeutics Advocacy CTAG

Abstract readEditorial
In one paragraph

Article in BMJ global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Kaempferol activity onPharmaceutical biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Virulence · 2025
    Article
  11. Molecular biology of the cell · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Organoid-basedMicrobiology spectrum · 2025
    Article
  16. Article
  17. Article
  18. Vesicular mechanisms of drug resistance in apicomplexan parasites.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  19. Deciphering Transcription inbioRxiv : the preprint server for biology · 2025
    Article
  20. Discovery of an Orally Efficacious Pyrazolo[3,4-Journal of medicinal chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ian H GilbertDDU, University of Dundee, Dundee, UK.
Sumiti VinayakDepartment of Pathobiology, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
Boris StriepenDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-7426-432X
Ujjini H ManjunathaGlobal Health, Novartis Institutes for BioMedical Research, Inc, Emeryville, California, USA.
Ibrahim A KhalilDepartment of Health, State of Washington, Seattle, Washington, USA.
Wesley C Van VoorhisMedicine, Div AID, University of Washington, Seattle, Washington, USA wesley@uw.edu.ORCID 0000-0001-6141-2015
Cryptosporidiosis Therapeutics Advocacy Group CTAG
Cryptosporidiosis Therapeutics Advocacy CTAG

Funding

Medical Research Council MR/S019170/1Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CryptosporidiosisHumansNeglected DiseasesChild healthParasitology

Identifiers

PMID37541693
PMCPMC10407372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.